Eli Lilly Can't Slip Teva's Migraine Drug Patent Suit
Drugmakers Eli Lilly and Co. and Teva Pharmaceuticals must take their patent dispute over rival migraine medications to a jury, a Massachusetts federal judge said Monday, denying the bulk of the...To view the full article, register now.
Already a subscriber? Click here to view full article